Slides
Innovative immunotherapy for hypercholesterolaemia
PCSK9 as a therapeutic target to reduce LDL-C and the burden of ASCVD
Unmet clinical needs in lipid lowering: Focus on LDL-C
Inclisiran and the ORION clinical development program
PCSK9 inhibition: an overview of therapeutic approachesView all slides »Videos


Lerodalcibep: What does LIBerate-HeFH tell us?


Verve-101: Where are we up to with PCSK9 gene editing?


Apo(a) size and PAD revascularisation outcomes: What’s the link?


Lepodisiran: What progress towards Lp(a) reduction?
View all videos »Events
American College of Cardiology Scientific Sessions 2026
Event start date: 28 Mar 2026
New Orleans, USA
94th European Atherosclerosis Society Congress 2026
Event start date: 24 May 2026
Athens, Greece
European Society of Cardiology Congress 2026
Event start date: 28 Aug 2026
Munich, Germany & online
View all events »
Event start date: 28 Mar 2026
New Orleans, USA
94th European Atherosclerosis Society Congress 2026
Event start date: 24 May 2026
Athens, Greece
European Society of Cardiology Congress 2026
Event start date: 28 Aug 2026
Munich, Germany & online
View all events »



